CDMOs in Austria: 5 compared (2026)
5 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Austria. None has revenue over €1bn. 0 sit between €250m and €1bn and 5 are smaller or niche.
By ownership: 4 family-owned and 1 private equity. The most common capabilities are sterile fill-finish (4), biologics and biosimilars (1), mRNA and LNP (1), viral vector and vaccine (1) and small-molecule API (1). 2 of the 5 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.
5 companies
CDMOs in Austria
| Company | HQ | Ownership | Size | Revenue (as reported) | Modalities | Data |
|---|---|---|---|---|---|---|
| Croma-PharmaFamily-owned hyaluronic-acid specialist that contract-manufactures HA prefilled syringes for ortho/ophthalmology partners. | Leobendorf | Family-ownedPrinz family | Tier 3 | not disclosed | Sterile fill-finish | medium |
| EVER PharmaSpecialty-injectables pharma that also runs a full CDMO for complex sterile injectables (cytotoxics, hormones, suspensions). | Unterach | Family-ownedB.F.H. Privatstiftung | Tier 3 | not disclosed | Sterile fill-finish | medium |
| Polymun ScientificFamily-owned biopharma/liposome-LNP CDMO; scaled the LNP process for the BioNTech/Pfizer Comirnaty vaccine. | Klosterneuburg | Family-owned | Tier 3 | not disclosed | Biologics and biosimilars, mRNA and LNP, Viral vector and vaccine | high |
| Richter PharmaFamily pharma group with a GMP contract-manufacturing unit for injectable solutions and semi-solids. | Wels | Family-owned | Tier 3 | not disclosed | Sterile fill-finish | medium |
| Sanochemia PharmazeutikaCDMO for sterile injectables and small-molecule APIs; also a leading MRI/CT contrast-agent maker. | Neufeld an der Leitha | Private equityEOSS Industries consortium | Tier 3 | not disclosed | Small-molecule API, Sterile fill-finish | high |
Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).
Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.
Browse the census
Other European CDMO lists
By country
- CDMOs in Italy (31)
- CDMOs in Spain (30)
- CDMOs in Germany (28)
- CDMOs in the United Kingdom (25)
- CDMOs in France (15)
- CDMOs in Switzerland (14)
- CDMOs in Poland (11)
- CDMOs in Belgium (9)
- CDMOs in Sweden (9)
- CDMOs in Greece (8)
- CDMOs in Ireland (8)
- CDMOs in the Netherlands (8)
- CDMOs in Portugal (8)
- CDMOs in Denmark (7)
- CDMOs in Austria
- CDMOs in Finland (5)
- CDMOs in Norway (5)
- CDMOs in Czechia (4)
- CDMOs in Lithuania (4)
- CDMOs in Bulgaria (3)
By modality
- Small-molecule API CDMOs in Europe (107)
- Oral solid dose CDMOs in Europe (94)
- Sterile fill-finish CDMOs in Europe (106)
- Biologics and biosimilars CDMOs in Europe (66)
- Monoclonal antibody CDMOs in Europe (36)
- Antibody-drug conjugate (ADC) CDMOs in Europe (15)
- Cell and gene therapy CDMOs in Europe (29)
- mRNA and LNP CDMOs in Europe (22)
- Viral vector and vaccine CDMOs in Europe (32)
- Microbial and protein CDMOs in Europe (34)
- Peptide CDMOs in Europe (24)